InvestorsObserver
×
News Home

Cannabis Stock Drops 7.81% Tuesday: Should You Buy Tilray Inc (TLRY)?

Tuesday, July 27, 2021 01:10 PM | InvestorsObserver Analysts

Mentioned in this article

Cannabis Stock Drops 7.81% Tuesday: Should You Buy Tilray Inc (TLRY)?

Cannabis stock Tilray Inc is lower by 7.81% Tuesday. Tilray Inc (TLRY) is near the top in its industry group according to InvestorsObserver. TLRY gets an overall rating of 37. That means it scores higher than 37 percent of stocks. Tilray Inc gets a 78 rank in the Drug Manufacturers - Specialty & Generic industry. Drug Manufacturers - Specialty & Generic is number 137 out of 148 industries.

Overall Score - 37
TLRY has an Overall Score of 37. Find out what this means to you and get the rest of the rankings on TLRY!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 37 would rank higher than 37 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes

InvestorsObserver

’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Tilray Inc Stock Today?

Tilray Inc (TLRY) stock is trading at $12.63 as of 1:09 PM on Tuesday, Jul 27, a decline of -$1.07, or -7.81% from the previous closing price of $13.70. The stock has traded between $12.59 and $13.65 so far today. Volume today is 16,067,901 compared to average volume of 18,730,853. Click Here to get the full Stock Report for Tilray Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App